News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
347,687 Results
Type
Article (18013)
Company Profile (94)
Press Release (329580)
Multimedia
Podcasts (42)
Webinars (9)
Section
Business (100180)
Career Advice (429)
Deals (18490)
Drug Delivery (66)
Drug Development (39422)
Employer Resources (62)
FDA (8984)
Job Trends (8329)
News (168117)
Policy (15497)
Tag
Academia (1483)
Academic (1)
Accelerated approval (2)
Adcomms (4)
Allergies (50)
Alliances (28533)
ALS (42)
Alzheimer's disease (827)
Antibody-drug conjugate (ADC) (78)
Approvals (9061)
Artificial intelligence (183)
Autoimmune disease (11)
Automation (10)
Bankruptcy (104)
Best Places to Work (7192)
BIOSECURE Act (11)
Biosimilars (67)
Biotechnology (52)
Bladder cancer (45)
Brain cancer (9)
Breast cancer (169)
Cancer (1378)
Cardiovascular disease (118)
Career advice (383)
Career pathing (10)
CAR-T (77)
Cell therapy (246)
Cervical cancer (14)
Clinical research (32494)
Collaboration (634)
Compensation (246)
Complete response letters (6)
COVID-19 (2405)
CRISPR (28)
C-suite (185)
Cystic fibrosis (73)
Data (1422)
Denatured (19)
Depression (25)
Diabetes (151)
Diagnostics (3799)
Digital health (13)
Diversity (5)
Diversity, equity & inclusion (16)
Drug discovery (68)
Drug pricing (30)
Drug shortages (13)
Duchenne muscular dystrophy (45)
Earnings (33990)
Editorial (24)
Employer branding (11)
Employer resources (55)
Events (54792)
Executive appointments (525)
FDA (9846)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (5)
Funding (486)
Gene editing (68)
Generative AI (15)
Gene therapy (181)
GLP-1 (399)
Government (2825)
Grass and pollen (4)
Guidances (75)
Healthcare (10493)
Huntington's disease (2)
IgA nephropathy (22)
Immunology and inflammation (61)
Indications (23)
Infectious disease (2541)
Inflammatory bowel disease (91)
Inflation Reduction Act (2)
Influenza (51)
Intellectual property (68)
Interviews (49)
IPO (8484)
IRA (14)
Job creations (1521)
Job search strategy (347)
Kidney cancer (4)
Labor market (11)
Layoffs (211)
Leadership (8)
Legal (2482)
Liver cancer (41)
Lung cancer (224)
Lymphoma (93)
Machine learning (4)
Management (19)
Manufacturing (232)
MASH (47)
Medical device (7674)
Medtech (7678)
Mergers & acquisitions (10416)
Metabolic disorders (380)
Multiple sclerosis (44)
NASH (12)
Neurodegenerative disease (45)
Neuropsychiatric disorders (9)
Neuroscience (1140)
NextGen: Class of 2025 (2686)
Non-profit (3342)
Now hiring (15)
Obesity (187)
Opinion (96)
Ovarian cancer (55)
Pain (38)
Pancreatic cancer (52)
Parkinson's disease (100)
Partnered (14)
Patents (137)
Patient recruitment (74)
Peanut (31)
People (33537)
Pharmaceutical (34)
Pharmacy benefit managers (1)
Phase I (8973)
Phase II (13496)
Phase III (12912)
Pipeline (832)
Policy (80)
Postmarket research (1245)
Preclinical (3210)
Press Release (64)
Prostate cancer (63)
Psychedelics (14)
Radiopharmaceuticals (154)
Rare diseases (227)
Real estate (3249)
Recruiting (24)
Regulatory (11633)
Reports (21)
Research institute (1531)
Resumes & cover letters (48)
Rett syndrome (2)
RNA editing (2)
RSV (50)
Schizophrenia (43)
Series A (80)
Series B (58)
Service/supplier (4)
Sickle cell disease (35)
Special edition (5)
Spinal muscular atrophy (108)
Sponsored (24)
Startups (1665)
Stomach cancer (8)
Supply chain (52)
Tariffs (19)
The Weekly (22)
Vaccines (814)
Venture capitalists (16)
Weight loss (110)
Women's health (17)
Worklife (4)
Date
Today (157)
Last 7 days (502)
Last 30 days (1725)
Last 365 days (19763)
2025 (6799)
2024 (20941)
2023 (23408)
2022 (33280)
2021 (36375)
2020 (33937)
2019 (25524)
2018 (19372)
2017 (17037)
2016 (16194)
2015 (18431)
2014 (13450)
2013 (10694)
2012 (11592)
2011 (11478)
2010 (9993)
Location
Africa (451)
Alabama (32)
Alaska (5)
Arizona (73)
Arkansas (8)
Asia (25065)
Australia (4055)
California (3267)
Canada (1115)
China (462)
Colorado (129)
Connecticut (142)
Delaware (106)
Europe (54006)
Florida (487)
Georgia (133)
Hawaii (1)
Idaho (20)
Illinois (285)
India (27)
Indiana (236)
Iowa (7)
Japan (152)
Kansas (43)
Kentucky (12)
Louisiana (3)
Maine (32)
Maryland (618)
Massachusetts (2595)
Michigan (172)
Minnesota (186)
Mississippi (1)
Missouri (60)
Montana (27)
Nebraska (14)
Nevada (31)
New Hampshire (51)
New Jersey (1238)
New Mexico (18)
New York (1024)
North Carolina (593)
North Dakota (7)
Northern California (1450)
Ohio (135)
Oklahoma (7)
Oregon (11)
Pennsylvania (840)
Puerto Rico (6)
Rhode Island (20)
South America (566)
South Carolina (9)
South Dakota (1)
Southern California (1218)
Tennessee (54)
Texas (419)
United States (13222)
Utah (83)
Virginia (79)
Washington D.C. (31)
Washington State (279)
West Virginia (1)
Wisconsin (32)
347,687 Results for "aeras global tb vaccine foundation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
IAVI and Zendal Announce Funding for Efficacy Trial of Promising TB Vaccine Candidate in Africa
IAVI today announced that the Bill & Melinda Gates Foundation has awarded IAVI US$55 million to conduct a Phase IIb trial assessing the safety and efficacy of the tuberculosis (TB) vaccine candidate MTBVAC to prevent active TB lung disease in adolescents and adults.
December 18, 2023
·
7 min read
Business
Gates Foundation, Wellcome Pledge $550M for Phase III Trial of GSK’s TB Vaccine
The funds will support a trial of a tuberculosis vaccine developed by GSK that could potentially be the first new TB shot in a century.
June 28, 2023
·
2 min read
·
Connor Lynch
Press Releases
Vaxxas Appoints Leading Global Vaccine Experts as the Company Advances its Needle-Free Vaccination Technology Towards Late-Stage Clinical Trials
February 6, 2025
·
6 min read
BioForest
New Tuberculosis Test Could Improve TB Care Globally by Increasing Access to Testing in Low- and Middle-Income Countries
A new tuberculosis test disclosed in the Association for Diagnostics & Laboratory Medicine’s Clinical Chemistry journal would allow testing for TB treatment monitoring to occur outside of a biosafety level 3 laboratory.
March 14, 2024
·
4 min read
Press Releases
Bavarian Nordic Partners with Biological E Limited to Expand Global Access to Chikungunya Vaccine
February 25, 2025
·
6 min read
Press Releases
Longhorn Vaccines and Diagnostics Presents Compelling Data on LHNVD-303 Vaccine for Sepsis Related to Bacterial Infections at the World Vaccine Congress
April 25, 2025
·
4 min read
Press Releases
SK bioscience Initiates Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate
February 25, 2025
·
5 min read
Infectious disease
Bavarian Nordic Accelerates Mpox Vaccine Production to Respond to Global Emergency
The Danish company on Saturday announced plans to increase production of its vaccine Jynneos on the heels of the World Health Organization last week declaring mpox a global health emergency.
August 19, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Inteleos Foundation Announces Two New Global Health Leaders to 2025 Board Directors
January 23, 2025
·
2 min read
Press Releases
Bristol Myers Squibb Foundation, Texas Children’s Global HOPE, & Baylor College of Medicine Global Health Launch Program to Combat Sickle Cell Disease in Sub-Saharan Africa
January 17, 2025
·
8 min read
1 of 34,769
Next
